Focus on Inventing Medicines for Rare Diseases: Kalam Tells Pharma Students

Published: 21st March 2015 06:00 AM  |   Last Updated: 21st March 2015 04:58 AM   |  A+A-


HYDERABAD:There is a need for a coordinated effort for more research and understanding of rare diseases in the country. To cure these rare diseases, the pharma industry must focus on inventing new  medicines, former President of India APJ Abdul Kalam has said. There are around 10 identified rare diseases in India, he said.

Addressing the students at the fourth convocation of the National Institute of Pharmaceutical Education and Research (NIPER) here on Friday, Kalam advised the pharma students to focus more on innovation of new medicines that can cure rare diseases. 

Kalam also felt that the current pharmacy education should be upgraded to provide continuous education to pharma professionals. The colleges can have a collaboration programme with pharma industries and hospitals for designing a  continuing education course, the former President suggested.

NIPER, Hyderabad, already has plans for industry-academic collaboration and its is going enter into an Memorandum of understanding (MoU) with Dr Reddy’s laboratories and Indian Drugs and Pharmaceutical limited (IDPL). Ninety seven students were awarded PG degrees at the convocation ceremony.

NIPER, which is going to set up its new campus at Genome Valley at Shameerpet in the coming three years, is planning to establish a national center for research and development in bulk drugs to cater to the R&D needs of the bulk drug industry, said Dr Ahmed Kamal, project director, NIPER, Hyderabad.

Dr VK Subburaj, secretary, department of pharmaceuticals, Union ministry of chemicals and fertilisers, Dr Laxmi Kantam, director, IICT and Dr Ariz Ahammed, joint secretary, department of pharmaceuticals were also present. 

Stay up to date on all the latest Hyderabad news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp